Gastroenterology and Hepatology

Track5:Colorectal Cancer: Early Detection, Diagnosis, and Therapeutics

Colorectal cancer (CRC) remains one of the leading causes of cancer-related deaths worldwide. This track focuses on the latest advancements in early detection, diagnostic tools, and therapeutic options for managing colorectal cancer, a disease that can be more effectively treated when caught at an early stage.

Diagnosis:

Once a potential case of CRC is identified, imaging technologies (e.g., CT scans, MRI, and PET scans) and biopsy techniques are crucial for confirming the diagnosis and staging the cancer. Advanced endoscopic procedures allow for more accurate detection of polyps and early-stage tumors. Genetic testing is also playing a significant role in understanding the molecular profile of tumors, guiding treatment decisions, and providing personalized therapeutic strategies.

Therapeutics:

Treatment for colorectal cancer depends on the stage of the disease. Surgical resection remains the cornerstone for early-stage CRC. For more advanced stages, chemotherapy, radiation therapy, and targeted therapies like monoclonal antibodies (e.g., anti-EGFR and anti-VEGF) have shown promising results. Immunotherapies, particularly checkpoint inhibitors like PD-1 and CTLA-4 inhibitors, have revolutionized treatment for some advanced CRC patients. Ongoing research into personalized medicine and novel drug combinations continues to improve outcomes and reduce side effects, offering hope for better long-term survival and quality of life.